Bo Tu

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Chinese PLA General Hospital(Current)

Southern Medical University

Chinese People's Liberation Army

Peking University

Bo Tu is an author at Chinese PLA General Hospital specializing in oncology, checkpoint inhibitor therapy, and programmed cell death protein 1 (pd-1) pathway.

Publications per year

2022–2023

Publications

Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer

Yingying Yu, Siyu Wang, Nan Su et al. · Frontiers in Oncology · 2022 · 43 citations · Full text

Life Sciences, Immunology, Oncology +17

Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational Therapy

Shida Pan, Yingying Yu, Siyu Wang et al. · Frontiers in Immunology · 2022 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17

Radiofrequency ablation combined with toripalimab for recurrent hepatocellular carcinoma: A prospective controlled trial

Zhenyu Wen, Junxiao Wang, Bo Tu et al. · Cancer Medicine · 2023 · 17 citations · Full text

Medicine, Oncology, Oncologic Surgery +13

1–3 of 3